tetradecanoylphorbol acetate has been researched along with Hyperprolactinaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco-Favela, F; Chavez-Rueda, K; Hérnández, J; Leaños-Miranda, A; Legorreta-Haquet, MV; Zenteno, E | 1 |
| Selmanoff, M; Shu, C | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Hyperprolactinaemia
| Article | Year |
|---|---|
Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes.
Topics: Adult; Antibodies; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; B-Lymphocytes; B7-2 Antigen; CD4-Positive T-Lymphocytes; CD40 Ligand; Cell Proliferation; Concanavalin A; Cytokines; Female; Flow Cytometry; Humans; Hyperprolactinemia; Immunologic Factors; Interferon-gamma; Interleukin-2; Lectins, C-Type; Leukocytes, Mononuclear; Lymphocyte Activation; Membrane Glycoproteins; Prolactin; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2005 |
Phorbol esters potentiate rapid dopamine release from median eminence and striatal synaptosomes.
Topics: Animals; Calcimycin; Calcium; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Hyperprolactinemia; Indomethacin; Kinetics; Male; Median Eminence; Phorbol Esters; Potassium; Protein Kinase C; Rats; Rats, Inbred Strains; Sphingosine; Synaptosomes; Tetradecanoylphorbol Acetate; Tritium; Veratridine | 1988 |